Pilot Study to Evaluate the Satiating Effect Using Different Gummies With Encapsulated Flavours in a Group of Healthy Overweight Subjects
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 12
- Locations
- 1
- Primary Endpoint
- Change from Baseline Satiety Hunger Assessment
Study Overview
Brief Summary
The purpose of this study is to evaluate the satiating effects of different gummies with encapsulated flavour on overweight subjects (BMI ≥25 and <30 kg / m2). Some studies have shown that the contribution of different flavours could reduce food intake. This have made grown the interest of food industry in incorporate these compounds in food and to being able to develop new functional foods into the control of body weight, as well as variables of glucose metabolism and lipid profile, which can contribute to te prevention of cardiovascular diseases.
Detailed Description
A randomized, cross-over and double-blind pilot study with 3 study arms is being performed to evaluate the satiating properties of the encapsulated flavours in different gummies in a group of healthy overweight subjects.
The investigators included 12 participants (6 men and 6 women) between 18 and 55 years (BMI ≥25 and <30 kg / m2). All volunteers will be randomized into 3 study groups, and participants will receive the 3 different study products in order during the 3 experimental phases.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Other
- Masking
- Double (Participant, Investigator)
Masking Description
Double Blind (Participant and Investigator)
Eligibility Criteria
- Ages
- 18 Years to 55 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Men and women from 18 to 65 years old.
- •Body Mass Index (BMI) ≥25 and <30 kg/m
- •Adequate cultural level and understanding for the clinical trial.
- •Signed informed consent
Exclusion Criteria
- •Subjects with BMI ≥30 or <25 kg /m2
- •Subjects diagnosed with Diabetes Mellitus.
- •Subjects with dyslipidemia on pharmacological treatment
- •Subjects with hypertension on pharmacological treatment
- •Subjects with established diagnosis of eating disorder
- •Smokers or those subjects with high alcohol consumption (> 2-3 servings/day in men and> 1 serving/day in women (1 serving = 1 glass of wine or 1 bottle of beer)
- •Subjects under pharmacological treatment (except oral contraceptives)
- •Subjects with large weight fluctuations of more than 4 kg or who have undergone in six months a weight loss diet
- •Subjects with sensory problems
- •Subjects with gastrointestinal diseases that affect the digestion or absorption of nutrients
- •Pregnant or breastfeeding women
- •Women with menstrual irregularities (absence of menstrual cycle at least 2 months)
- •Subjects with intense physical activity.
- •Subjects with food allergies to meals included in breakfast, study product or lunch or that reject their consumption
- •Subjects with a diagnosis of celiac disease or a gluten intolerance
Arms & Interventions
Control Gummy
Control gummy with free flavour (without encapsulating)
Intervention: Control gummy with free flavour (without encapsulating) (Other)
Gummy Variety 1
Experimental gummy with 50% free/50% encapsulated flavour
Intervention: Experimental gummy with 50% free/50% encapsulated flavour (Other)
Gummy Variety 2
Experimental gummy with 100% encapsulated flavour
Intervention: Experimental gummy with 100% encapsulated flavour (Other)
Outcomes
Primary Outcomes
Change from Baseline Satiety Hunger Assessment
Time Frame: Day 1, 8, 15
Visual Analogue Scale (VAS). 100mm horizontal line anchored at each end with the extremes of the subjective feeling to be quantified. Subjects are instructed to rate the sensation being experienced according to how they define the line. e.g., "not at all hungry" (0mm) and "as hungry as I have ever felt" (100mm). Multiple measures are taken at repeated time intervals described below.
Secondary Outcomes
- Anthropometric Parameters(Day 1, 8, 15)
- Change from Baseline Glucose Metabolism Parameters(Day 1, 8, 15)
- Change from Baseline Lipid Metabolism Parameters(Day 1, 8, 15)
- Change from Baseline Blood Hormonal Satiety Markers(Day 1, 8, 15)
- Amount of food consumed in a "food ad libitum"(Day 1, 8, 15)
- Total amount of food consumed in 24h(Day 1, 8, 15)
- Sensory Perception(Day 1, 8, 15)
- Adverse Effects(Day 1, 8, 15)